Zimmer's Centerpulse bid gains regulatory nod:
This article was originally published in Clinica
Warsaw, Indiana orthopaedics group Zimmer has received US and European antitrust clearance for its proposed acquisition of Centerpulse of Switzerland. However, it has postponed a related shareholder vote, partly because of uncertainty over the position of rival bidder Smith & Nephew, and partly because of the delaying effect of appeals by all three parties to the Swiss Federal Banking Commission over terms and timeframes imposed on the bidding process. The meeting, during which shareholders will vote on the issue of shares, will now take place on July 30 instead of July 22.